Pediatric Hematology-Oncology

Heme-Onc Emergencies
 
Hematology

General
Neonatal Hematology
Neonatal Bleeding
Hematologic Inborn Errors
Marrow Failure Syndromes
Cell Surface Markers

Transfusion: 
Risks, Complications
Acute Transfusion Reaction

Hemolysis
Hemolytic Uremic Syndrome
Thrombotic Thrombocytopenic Purpura

Hemophilia and Thrombosis
Hemophilia and Factor Replacement
Inherited Factor Deficiencies
Coag Parameters in Newborns
Enoxaparin Therapy Guidelines
Unfractionated Heparin Protocol
Work Up for Hypercoagulability
Stimate Guidelines
Warfarin: Dosing and Reversal
 

Red Cell
Anemia: microcytic, normocytic
Sickle Cell Management
Hemoglobin Electrophoresis
Management of Thal Major

White Cell
Neutrophil Disorders and Neutropenia Drugs

Platelet
 

Oncology

General
Palliative Care

Liquid Tumors:
Lymphoma: Hodgkins and Non-Hodgkins
Leukemia:  ALL, AML and APML
Myeloid Disorders

Solid Tumors
Neuroblastoma
 
 

DNA-Interactive Drugs

Automated Heme-Onc Protocols:
IV Iron Dextran Infusion
IVIG Infusion
 
Net Scut Home


Please direct all comments to: addy
Last modification: June 28, 1998